ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

STX Shield Therapeutics Plc

1.55
-0.10 (-6.06%)
03 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Shield Therapeutics Plc LSE:STX London Ordinary Share GB00BYV81293 ORD 1.5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.10 -6.06% 1.55 1.50 1.60 1.65 1.475 1.65 8,522,072 16:15:29
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 4.47M -40.44M -0.0522 -0.30 12.02M
Shield Therapeutics Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker STX. The last closing price for Shield Therapeutics was 1.65p. Over the last year, Shield Therapeutics shares have traded in a share price range of 1.075p to 12.75p.

Shield Therapeutics currently has 775,429,360 shares in issue. The market capitalisation of Shield Therapeutics is £12.02 million. Shield Therapeutics has a price to earnings ratio (PE ratio) of -0.30.

Shield Therapeutics Share Discussion Threads

Showing 7976 to 8000 of 23250 messages
Chat Pages: Latest  330  329  328  327  326  325  324  323  322  321  320  319  Older
DateSubjectAuthorDiscuss
09/3/2021
22:14
$200k per rep per year fully loaded, so team of 60 field-based staff = $12m per year. Add in office-based staff,manufacturing costs (handled via transfer pricing with UK parent), promotional costs etc... and you get to their cost forecast.

Simply put... early revenues and listing by major US private payors absolutely key as those things will engender confidence, bring in US investors, allow reasonably priced further fund raising if required and perhaps even lead to a joint listing (& associated valuation rerating) on NASDAQ.

Fingers crossed.

innittowinit
09/3/2021
17:37
Did he say SG&A $45M pa in 2-3 years?
I reckon 60reps c$5m the big cost i would think so where does $45M come from?
If it accelerates to anywhere near that it spells trouble

powerp2
09/3/2021
17:14
@ power That was me..."Mr Groch. In 4 of your last 5 jobs you lasted approximately a year. Should we be worried about your longevity?"
t0pgrader
09/3/2021
17:13
I suggested that before but he ignored it
When TW asked how long is left (no clock on his laptop !?!?!) he might just as well have said wrap this up and bale me out please

powerp2
09/3/2021
17:10
From the detailed market Research opportunity in the states which if you believe looks substantial with great pricing power why in 18 months couldn’t they get a licensing deal done it’s a real mystery.
But I liked Brian he obviously knows the market place extremely well and if they deliver
as planned then today’s valuation is a giveaway

best1467
09/3/2021
17:06
Yes, launch in US, and he says sometime Q2, probably late (groan). Just give the month !
Could AZN snap them up to go alongside their product I wonder ....

daveboy19
09/3/2021
17:06
Someone touched a nerve with BG let's hope he proves them wrong!
powerp2
09/3/2021
17:03
I like straight talk and a clear business plan with measurable and timelines - this was missing.
The "launch plan" on page 21 is a generic slide for launching a pharmacy product - where was the timings? I'dlike to see a detailed cash flow forecast as if we don't see revenues fast 're cash burn will hit even harder and we'll run out again

powerp2
09/3/2021
16:46
Our CEO is a truly dire presenter. Awful
toffeeman
09/3/2021
16:11
As usual, hissing the time away, when we all want to talk route to market. FFS.
daveboy19
09/3/2021
12:14
Still think better entry after Agm when placees will dump
nico115
09/3/2021
09:21
Too true, powerp2. Let's hope they get onto Brian asap, and he has plenty of drive to recharge this beast.
daveboy19
09/3/2021
09:16
Anyone know the actual number of patients each month and the actual value of sales in each territory? Would be great to know these stats to work out the speed of the roll out. With huge margins getting traction on the volumes is critical to profits.
sharpshare
09/3/2021
09:06
I agree Daveboy19. It might also encourage a more balanced approach to the placing price.
The timing of news I believe is manipulated but not only by Shield it is widespresd. Then of course what is news?
Directors no doubt would argue about its materiality.
Bottom line for me is as much timely transparency as possible.
I wonder if TW tries to dine out on this today.
I want to hear about a robust US plan with key milestones identified for review and not flannel

powerp2
09/3/2021
08:44
Surely news cannot be withheld and released as and when the company chooses, but only when it is known...
Should put a 180 day clause on sale of placing shares to properly support the company going forward and not just flip an easy profit to it's detriment.

daveboy19
09/3/2021
08:22
Wouldn't it better to release these sorts of news after placing shares have hit the market as any rise may get sold into due to the price being at premium now
78steve
09/3/2021
07:37
The Cap here is ridiculous. Take advantage of it. Load up if you can.
hodhasharon
09/3/2021
07:23
Good news !! Simple .. just buy back in pal !
amaretto1
09/3/2021
07:22
Stage managed or not it’s still a further territory to grow sales
best1467
09/3/2021
07:16
All very stage managed!
It's substance i want to see in top line revenue hopefully he'll tell us of a licensing sggreement to be signed there with a partner who will deliver and a decent down payment

powerp2
09/3/2021
07:13
Nice unexpected news for a change let’s see an impressive detailed confident presentation from Groch and hopefully the tide is beginning to turn
best1467
09/3/2021
07:03
Aussies r with us !! Onwards and upwards :-)
amaretto1
08/3/2021
17:09
Big trades at the end. Someone else is buying. Heading back up?
frrinvest
08/3/2021
14:59
Powerp, you might point out to them that Watts is one of the worst presenters they have ever given air time to, and that we really want to hear from Groch...
waggle
08/3/2021
14:50
Powerp2 I second that but I suspect they won't take up your suggestion.
frrinvest
Chat Pages: Latest  330  329  328  327  326  325  324  323  322  321  320  319  Older

Your Recent History

Delayed Upgrade Clock